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Summary  
Increased activity of the noradrenergic system in the amygdala has been suggested to 
contribute to the hyperarousal symptoms associated with post-traumatic stress disorder 
(PTSD). However, only two studies have examined the content of noradrenaline or its 
metabolites in the amygdala of rats previously exposed to traumatic stress showing 
inconsistent results. The aim of this study was to investigate the effects of an inescapable 
foot shock (IFS) procedure 1) on reactivity to novelty in an open-field (as an index of 
hyperarousal), and 2) on noradrenaline release in the amygdala during an acute stress. To 
test the role of noradrenaline in amygdala, we also investigated the effects of microinjections 
of propranolol, a β-adrenoreceptor antagonist, and clenbuterol, a β-adrenoreceptor agonist, 
into the amygdala of IFS and control animals. Finally, we evaluated the expression of mRNA 
levels of β-adrenoreceptors (β1 and β2) in the amygdala, the hippocampus and the prefrontal 
cortex. Male Wistar rats (3 months) were stereotaxically implanted with bilateral guide 
cannulae. After recovering from surgery, animals were exposed to IFS (10 shocks, 0.86 mA, 
and 6 seconds per shock) and seven days later either microdialysis or microinjections were 
performed in amygdala. Animals exposed to IFS showed a reduced locomotion compared to 
non-shocked animals during the first 5 minutes in the open-field. In the amygdala, IFS 
animals showed an enhanced increase of noradrenaline induced by stress compared to 
control animals. Bilateral microinjections of propranolol (0.5 μg) into the amygdala one hour 
before testing in the open-field normalized the decreased locomotion observed in IFS 
animals. On the other hand, bilateral microinjections of clenbuterol (30 ng) into the amygdala 
of control animals did not change the exploratory activity induced by novelty in the open field. 
IFS modified the mRNA expression of β1 and β2 adrenoreceptors in the prefrontal cortex 
and the hippocampus. These results suggest that an increased noradrenergic activity in the 
amygdala contributes to the expression of hyperarousal in an animal model of PTSD. 
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1. Introduction  
 
Post-traumatic stress disorder (PTSD) is an anxiety disorder that results from experiencing 
an extremely traumatic event and is defined as a long term, maladaptive stress response 
(Pitman et al., 2012; Yehuda et al., 2015). PTSD is characterized in part by symptoms of 
hyperarousal resulting from a non-associative general sensitization process (Dunsmoor and 
Paz, 2015; Pitman et al., 2012; Stam, 2007). Also, heightened heart rate reactivity to startling 
stimuli (loud tones) and larger skin conductance response to novel stimuli have been 
observed in PTSD patients (Pitman et al., 2012). In animal models, exaggerated acoustic 
startle response and reduced locomotor activity in a novel environment have been used as 
measures of hyperarousal after exposure to traumatic stressors (Hendriksen et al., 2010; 
Kinn Rød et al., 2012; Stam, 2007; van Dijken et al., 1992; Wang et al., 2012).  
 
Noradrenaline has a special role in mediating arousal and emotional memories, and is also 
involved in fear responses (Roozendaal and McGaugh, 2011; Sara, 2009). It has been 
proposed that an altered noradrenergic activity may contribute to the hyperarousal symptoms 
associated with PTSD (Krystal and Neumeister, 2009; O'Donnell et al., 2004; Southwick et 
al., 1999; Strawn and Geracioti, 2008). This proposal is based on studies showing that the 
reduction and increase of noradrenergic activity attenuated and precipitated, respectively, 
some of the symptoms in PTSD patients (Boehnlein and Kinzie, 2007; Bremner et al., 1997; 
Raskind et al., 2007; Southwick et al., 1993; Taylor et al., 2008). Additionally, the systemic 
treatment with pharmacological agents that reduce noradrenergic transmission normalized 
acoustic startle response in mice previously exposed to inescapable foot-shock (IFS) (Olson 
et al., 2011). Moreover, the evoked responses to a noxious event are higher in neurons of 
the locus coeruleus (primary source of noradrenaline in the forebrain) of rats previously 
exposed to single prolonged stress (George et al., 2013). 
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The amygdala is a key area involved in the recognition of dangerous stimuli and the 
coordination of fear response (LeDoux, 2007; Roozendaal and McGaugh, 2011). Indeed, it 
has been reported exaggerated amygdala activation in response to trauma-related stimuli as 
well as generic (neutral) stimuli in patients with PTSD compared to control subjects (Pitman 
et al., 2012; Rauch et al., 2006). Therefore, an increased stress-related noradrenergic 
activity in amygdala may contribute to the expression of hyperarousal symptoms in PTSD. 
Despite this, and to our knowledge, there are only two studies examining the content of 
noradrenaline or its metabolites in the amygdala of rats previously exposed to traumatic 
stress showing inconsistent results (Hendriksen et al., 2010; Tsuda et al., 1986). Moreover, 
no studies have monitored the in vivo release of noradrenaline in the amygdala or 
determined the causal relationship between these changes of noradrenaline outflow and the 
alterations of behavior in animals exposed to traumatic stress. Although the amygdala seems 
to be the main area upon which noradrenaline exerts its effects, other areas mediating fear 
processing such as prefrontal cortex and hippocampus may also be involved (Pitman et al., 
2012). 
 
To investigate whether an enhanced noradrenergic activity in the amygdala is involved in 
PTSD-like behavioral changes, we exposed male Wistar rats to an IFS procedure. This 
paradigm induces both long-lasting conditioned and non-conditioned anxiety (Chen et al., 
2012; Daviu et al., 2010; Hendriksen et al., 2010; Hendriksen et al., 2012; Kinn Rød et al., 
2012; van Dijken et al., 1992). In particular, IFS procedure produces a reduction in the 
activity in unknown environments 7 days after exposure to the shock (Daviu et al., 2010; 
Hendriksen et al., 2010; van Dijken et al., 1993; van Dijken et al., 1992). This effect of IFS 
has been considered an index of hypervigilance similar to the hyperarousal observed in 
PTSD patients (Pitman et al., 2012; Stam, 2007). 
 
The specific aims of this study were to investigate: 1) the effect of IFS on the reactivity to 
novelty in an open-field (as an index of hyperarousal) and the noradrenaline release in the 
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amygdala during an acute restraint stress; 2) the effect of the amygdala injection of the β-
adrenoceptor antagonist propranolol on the changes in the reactivity to novelty produced by 
IFS; 3) the effect of the amygdala injection of the β-adrenoceptor agonist clenbuterol in 
control rats; and 4) the expression of mRNA levels of β-adrenergic (β1 and β2) receptors in 
the amygdala, the hippocampus and the prefrontal cortex of control and IFS rats. 
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2. Methods and Materials 
2.1 Animals 
Young adult male Wistar rats (Harlan, The Netherlands) were 4 weeks old (125-150 g) upon 
arrival. Experimental procedures started 2 months later. Animals were housed (2 animals per 
cage) and provided with food and water ad libitum and maintained in a temperature-
controlled room (22 ±2 ºC) under an inverted light/dark cycle (lights on at 20:00 – 8:00). The 
experiments were carried out during the dark phase of the cycle between 14:00 and 19:00. 
Three different sets of animals were used for a) evaluation of the behavioral effects of IFS 
procedure and mRNA quantification, b) microdialysis experiments, and c) microinjection 
experiments (Figure 1). All experiments carried out in our laboratory at the Universidad 
Complutense of Madrid followed the Spanish regulations for the protection of laboratory 
animals (RD53/2013). 
 
2.2 Inescapable Foot-Shock (IFS) procedure 
Rats were place in a shuttle-box divided into 2 compartments separated by a guillotine door. 
The starting compartment (light compartment, 50x50x20 cm) consisted on an open roof white 
plastic compartment illuminated by a 60 W bulb at 40 cm overhead. The shock compartment 
(dark compartment, 25x25x20 cm) was made of black plastic, a removable roof, no 
illumination, and an electrified grid floor. Rats were first place in the light compartment for 60 
seconds and then the guillotine door was opened. Once the animal entered in the dark 
compartment the door was closed and 10 shocks (0.86 mA) of 6 seconds duration in 10 
minutes were given. The conditions of the IFS procedure were based in previous studies 
(Hendriksen et al., 2010; Hendriksen et al., 2012; van Dijken et al., 1993; van Dijken et al., 
1992). Control animals remained 10 minutes in the dark compartment without receiving 
shocks. Rats were then placed back in their home cage during 7 days before experiments 
started. All animals were handled three times for 1 min before the exposure to the shuttle-
box/IFS procedure in order to habituate them to the experimenter.  
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2.3 Open field test  
Behavioral responses towards a novel context not associated with the IFS procedure were 
evaluated in open field arenas (MED Associates INC., St. Albans, USA). The open field 
apparatus consisted of a Plexiglas box (80x80x30 cm) equipped with two horizontal rows of 
eight infrared light sensitive photocell beams located at 5 and 15 cm, respectively, from the 
basement, allowing the detection of horizontal and vertical (rearing) motor activity. 
Interruptions of the photocell beams were registered automatically by computer software 
connected to the open field apparatus (MED Associates Inc., St. Albans, USA). Open field 
arenas were wiped with 70% ethanol between rats. Animals were placed in the center of the 
arena and activity was recorded every 5 min for a total time of 60 min. IFS-exposed rats 
spent more time in the center because of the reduction in the activity induced by the shocks 
(data not shown). 
 
2.4 Implantation of guide cannulae 
The procedures for the microinjections and microdialysis experiments were adapted from 
previous studies of the laboratory (del Arco et al., 2015; Ronzoni et al., 2016). Animals were 
anesthetized with equithesin (2.5 mg/kg i.p.) and received a subcutaneous dose of the local 
anesthetic lidocaine in the incision area (20 mg/ml) and the non-steroidal analgesic carprofen 
(4 mg/kg, i.m.) before been positioned in the stereotaxic apparatus (Kopf Instruments). 
Bilateral guide cannulae were implanted to reach the amygdala with the following 
coordinates according to Paxinos and Watson, 1998: -3.1 mm caudal, ±5 mm medial and -
5.5 or -6.5 mm (respectively for microdialysis and microinjection experiments) from the top of 
the skull, being the incisive bar set at -3.3 mm) (Paxinos and Watson, 1998). Stainless-steel 
guide cannulae [made in our own workshop], for microdialysis experiments (10 mm; 20-
gauge) or for microinjections (15mm; 23-gauge) experiments were fixated to the skull with 2-
3 anchoring screws (Angtho´s, Sthockholm, Sweden) and dental acrylic cement. Stainless-
steel dummy cannulae (24-gauge) were inserted into the guide to keep it clean and prevent 
occlusion. After surgery, the rats received a subcutaneous injection of 3 ml of saline to 
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facilitate clearance of drugs and prevent dehydration. One day after surgery rats were again 
group-housed two per cage and allowed to recover for a minimum of 7 days before 
submission to the IFS procedure. Wound from surgery, weight and general welfare of 
animals were monitored. 
 
2.5 Microdialysis experiments 
Microdialysis probes, [constructed in our own workshop], were of concentric design with an 
active dialysis membrane (5000 Da, Hospal, Barcelona,Spain) of 2 mm in length. Thus, the 
whole amygdala was perfused during the experiments (figure 3B). One day before the 
experiments, all animals were habituated to the mycrodialysis cages. In the experimental 
day, probes were perfused with artificial cerebrospinal fluid (CSF) consisting of (in mM): NaCl 
137; CaCl2 2.4; KCl 3; MgSO4 0.5; Na2HPO4 2; glucose 3; containing the inhibitor of 
noradrenaline transporter nomifensine (5 µM) at a flow rate of 2 µl/min. After basal 
concentrations of neurotransmitter were established (3 h perfusion period), 20 min samples 
were collected and immediately stored at -80º C until analyzed. The first three samples were 
used as a control (basal levels) and then it followed an acute stress period (40 min of restrain 
stress). Acute stress consisted of restraint by tightly wrapping the rat using a cloth tied with 
Velcro. 
 
2.6 HPLC analysis of noradrenaline 
Noradrenaline was analyzed by reverse-phase HPLC and electrochemical detection 
(HP1049A, Agilent, Palo Alto, USA). Samples were injected in a Rheodyne injector (20 µl 
loop) running in a C18 column of 4 µm particles, and 3.9x150 mm (Nova-pack, waters, 
Milford, MA). The mobile phase consisted of 0.1 M acetate-citrate buffer (pH = 3.2 adjusted 
with HCl and NaOH 1 N), 1 mM EDTA, 9 mM sodium octyl sulphonate, and 15% methanol. 
The mobile phase was re-circulated at a flow rate of 1 ml/min. These conditions allowed 
noradrenaline to be detected at 3.05 min. Noradrenaline was measured by a coulometric 
detector (Coulochem II model 5200, ESA). Conditioning cell (ESA 5011) was set at 0 mV and 
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analytical cells at +375 mV (cell 1) and -250 mV (cell2). Chromatograms were processed 
using the Millenium software (waters). The limit of detection for noradrenaline (20 µl 
samples) was 0.15 nM. 
 
2.7 Microinjections into the amygdala and drugs 
Bilateral microinjections into de amygdala were performed using 30-gauge stainless steel 
injection cannulae, protruding 2 mm below the tip of the guide and attached to a 10 µl 
Hamilton microsyringe. By means of a micropump (Hardvard Apparatus, Holliston, MA, USA) 
an injection volume of 0.5 µl/side at a rate flow of 0.5 µl/min was injected maintaining the 
injection cannulae in place for 60 seconds to allow the diffusion of the drug/vehicle. The 
injection conditions, in particular the injection volume, allows the drugs to diffuse into the 
basolateral amygdala and surrounding amygdalar nuclei. The nonspecific β-adrenoceptor 
antagonist propranolol (Sigma-Aldrich, Spain) (0.1 µg, 0.5 µg and 1.5 µg per side) and the 
β2-adrenoceptor agonist clenbuterol (Sigma-Aldrich, Spain) (30 ng per side) were freshly 
dissolved in CSF that was also used as vehicle treatment, and injected 1 hour before placing 
the animal in the open field arena. Drug doses were based on previous studies performing 
microinjections into the amygdala and were within the range of those used to modulate 
emotional memory (Introini-Collison et al., 1995; LaLumiere and McGaugh, 2005; 
Roozendaal et al., 2008). 
 
2.8 Histology 
All animals used for microdialysis and microinjection experiments were anesthetized with an 
overdose of sodium pentobarbital (100 mg/kg i.p.) and perfused intracardially with 0.9% 
saline followed by 4% formaldehyde. The brains were removed and immersed in fresh 4% 
formaldehyde and then submerged in a 25% sucrose (wt/vol) solution in water for 
cryoprotection. Coronal sections of 50 µm were cut in a cryostat (Leica CM1510S) mounted 
in gelatin –coated slides, and stained with cresyl violet. The sections were examined and the 
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placement of the microdialysis probes and the injections cannulae was verified under a light 
microscope (Axioskop, Zeiss, Alemania) (figure 3 A and C). 
 
2.9 Real-time PCR 
For mRNA determination in brain tissue, rats were killed 2-3 days after open field test by 
decapitation between 9:00 and 11:00 and brains were immediately frozen by isopentane and 
dry ice and stored at -80 ºC. Punches from ventral-medial prefrontal cortex (including 
prelimbic and infralimbic subregions), dorsal hippocampus and amygdala were collected and 
stored again at -80º C. Total RNAs were purified from tissue by the single step procedure of 
Chomczynski and Sacchi (1987) using Tri-Reagent (Sigma, Spain) (Chomczynski and 
Sacchi, 1987). The concentration and purity of RNA extracted was determined by an 
automated electrophoresis system (Experion, Bio-Rad, USA). One microgram of total RNA 
extracted from the PFC tissue was reversed transcribed into first strand complementary DNA 
using GoScript Reverse Transcription system (Promega Biotech Ibérica, Spain). Real-time 
PCR was performed in iQ5 equipment using the SsoFast EvaGreen Supermix (Bio-Rad, 
USA) and 500 nM concentrations of specific primers. The sequences of the oligonucleotide 
primers used to amplify β1- and β2-adrenoceptors were as follows: β1: 
5´GCAGAACCAGTCTCACAGCTAA and 3´CGCCTTTCTACCTCTAGTGCAT; β2: 
5´CTCCTTAACTGGTTGGGGCTATG and 3´TCCCATAGGTTTTCGAAGAAGA. The amount 
of targets, normalized to an endogenous reference (18S ribosomic mRNA) and relative to a 
calibrator, was defined by the threshold cycle (Ct) methods (Livak and Schmittgen, 2001). In 
all runs, melting curves were performed to make sure that only the corresponding DNA 
fragment was amplified.  
 
2.10 Statistical analysis 
To analyze motor activity and dialysate concentration of noradrenaline, a two-way analysis of 
variance (ANOVA) design, with repeated measures when appropriate, was used to perform 
planned comparisons (a priori analysis), considering group (control or IFS) and time or drug 
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(propranolol or clenbuterol) as within- and between-subject factors, respectively. For the 
analysis of noradrenaline dialysate concentrations, samples collected prior to acute stress 
were average to yield a standard baseline level of 100%. Stress effect in noradrenaline was 
expressed as the percent change from these values. Student´s t test for independent 
samples was performed to analyze mRNA receptor quantification and the effects of 
clenbuterol injections. Statistical analyses were performed with STATISTICA software. 
Statistical signification was considered in all cases p < 0.05.  
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3. Results 
3.1 Effects of IFS in the exploratory activity in response to novelty.  
Total (60 min) exploratory activity in response to novelty was not significantly different 
between IFS and control animals (locomotion: F(1,17)= 4.44, p= 0.05; rearing: F(1,17)= 0.28, p= 
0.60) although there was a significant interaction between group and time factors 
(locomotion: F(11,187)= 10.33, p< 0.001; rearing: F(11,187)= 3.02, p= 0.001). IFS induced a lower 
exploratory activity in response to novelty during the first 5 minutes of the test compared to 
control animals (locomotion: F(1,17)= 92.94, p <0.001; rearing: F(1,17)= 20.76, p <0.001) (Figure 
2). 
 
3.2 Effect of IFS on the increase of extracellular concentration of noradrenaline in the 
amygdala induced by acute restraint stress. 
Basal dialysate concentration of noradrenaline in the amygdala (see cannulae location in 
figure 3A and B) of IFS animals were significantly lower than in control animals (control= 0.83 
± 0.09 nM; IFS= 0.39 ± 0.07 nM, F(1,19)= 14.96, p= 0.001).  
The effect of stress on the dialysate concentration of noradrenaline was calculated as the 
average of 80-120 min time samples. As shown in figure 4, an acute restraint stress 
increased significantly the dialysate concentration of noradrenaline in the amygdala of IFS 
(212.84 ± 13.72 %, F(1,19)= 27.48, p< 0.001) but not control (127.33 ± 2.67%, F(1,19)= 1.21, p= 
0.29) animals. There was a significant difference between IFS and control animals in the 
effect of stress on the dialysate concentration of noradrenaline in the amygdala (F(1,19)= 6.76, 
p= 0.018). 
3.3 Effects of propranolol and clenbuterol microinjections into the amygdala on the 
exploratory activity in response to novelty. 
For the study of the effects of amygdala microinjections, exploratory activity during the first 5 
minutes in the open field was analyzed. A two-way ANOVA showed a significant interaction 
between drug treatment (propranolol 0.5 µg vs vehicle) and IFS treatment (IFS vs control) 
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(locomotion: F(1,29)= 30,55, p< 0.001; rearing: F(1,28)= 5.46, p= 0.027). There was also a 
significant effect of the factor IFS treatment on novelty induced locomotion (F(1,29)= 29.39, p< 
0.001) and rearing (F(1,28)= 26.75, p< 0.001). As shows in figure 5, propranolol 0.5 µg injected 
into the amygdala of control animals reduced locomotion (F(1,29)= 11.78, p= 0.002) but not 
rearing (F(1,28)= 0.15, p=0.706). Propranolol microinjections at a dose of 0.5 µg in IFS animals 
significantly reversed the reduction in locomotion (F(1,29)= 19.36, p< 0.001) and rearing 
(F(1,28)=  8.50, p= 0.007) observed in the IFS animals treated with vehicle. The effects of 
injections of propranolol 0.1 or 1.5 µg in the amygdala of IFS animals were not significantly 
different from injections of propranolol 0.5 µg (Table 1).  
As shows in Table 1, clenbuterol (30 ng) injected into the amygdala of control animals did not 
change the exploratory activity (5 first minutes) induced by novelty in the open field 
(locomotion t(13)= 0.77, p=0.453; rearing t(13)= 1.11, p= 0.287). 
3.4 Effect of IFS on mRNA levels of β-adrenoceptors (β1 and β2) in the amygdala, 
ventral-medial prefrontal cortex and dorsal hippocampus.  
As shown in Table 2, IFS did not significantly modify the mRNA levels of β-adrenoceptors in 
the amygdala (β1: t(17)= 1.77,p= 0.095; β2: t(16): 0.12, p= 0.908) nor in the medial prefrontal 
cortex (β1: t(15)= 0.91, p= 0.378; β2: t(14): 2.03 , p=0.062) but enhanced the mRNA levels of β-
adrenoceptors in the dorsal hippocampus (β1: t(13)= 2.52, p= 0.026; β2: t(13)=  2.25, p= 0.043).  
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4. Discussion  
 
The aim of the present study was to investigate whether an enhanced noradrenergic activity 
in the amygdala is involved in the hyperarousal symptoms observed in PTSD. For that, we 
exposed male Wistar rats to IFS and a week later we measured reduced locomotion in a 
novel environment as an index of PTSD-like hyperarousal (Hendriksen et al., 2010; 
Hendriksen et al., 2012; van Dijken et al., 1992). This study shows for the first time that 
exposure to IFS enhances stress-induced noradrenaline extracellular concentration in the 
amygdala and that the blockade of β-adrenoceptors through local injections of propranolol 
counteracts the reduced exploratory activity produced by IFS. These findings suggest that 
IFS causes a sensitization of the noradrenergic projections to the amygdala that mediates, at 
least in part, the behavioral sequelae of IFS (hyperarousal). 
 
Several findings support the hypothesis that an enhanced noradrenergic activity in the 
amygdala is involved in hyperarousal symptoms of PTSD patients (Krystal and Neumeister, 
2009; O'Donnell et al., 2004; Southwick et al., 1999; Strawn and Geracioti, 2008). First, the 
amygdala is a key structure mediating emotional arousal and the effects of stress hormones 
on cognitive function (LeDoux, 2007; Roozendaal and McGaugh, 2011). As well, an 
exaggerated activation of the amygdala in response to trauma-related, and also neutral, 
stimuli has been reported in PTSD patients (Pitman et al., 2012; Rauch et al., 2006). Second, 
noradrenaline release in the amygdala seems to play a critical role in mediating the effects of 
emotional arousal on learning and memory (Roozendaal and McGaugh, 2011; Sara, 2009).  
Moreover, the reduction and increase of noradrenergic activity attenuated and precipitated, 
respectively, some of the symptoms in PTSD patients (Boehnlein and Kinzie, 2007; Bremner 
et al., 1997; Raskind et al., 2007; Southwick et al., 1993; Taylor et al., 2008). Evidence of 
noradrenaline dysregulation have been also shown in several studies measuring 
noradrenaline in the urinary system and in plasma of PTSD patients (reviewed in (Strawn 
and Geracioti, 2008). However, noradrenaline levels in the periphery do not necessarily 
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mirror those in the brain since they are derived from largely disparate sources. Interestingly, 
Geracioti et al. found a higher CSF noradrenaline concentrations in men with PTSD than in 
healthy men and also a positive correlation between CSF noradrenaline levels and the 
severity of PTSD symptoms (Geracioti et al., 2001). 
 
In the present study we used the microdialysis technique to measure noradrenaline levels in 
the amygdala of IFS rats. As shown in the results section, basal dialysate concentrations of 
noradrenaline in the amygdala were reduced in animals exposed to IFS. Moreover, the 
percentage increase of dialysate noradrenaline evoked by acute restraint stress was 
enhanced in the amygdala of IFS rats. These results are in accord with a previous study in 
which exposure of rats to a single prolonged stress lowered spontaneous activity but 
increased the evoked response of neurons in the locus coeruleus, the main source of 
noradrenaline in the forebrain (George et al., 2013). Moreover, the sensitization of the 
noradrenergic system has been also observed after chronic stress exposure (Adell et al., 
1988; Jedema and Grace, 2002; Nisenbaum et al., 1991). The reduced basal levels of 
noradrenaline found in the present study may be the consequence of an enhanced sensitivity 
of α2-adrenergic inhibitory autoreceptors in noradrenaline neurons (Aghajanian and 
VanderMaelen, 1982; Strawn and Geracioti, 2008). However, this change in α2-
adrenoreceptors cannot account for the enhanced release of noradrenaline after stress. 
Alternatively, the lower basal release of noradrenaline could be the result of an increased 
expression of the noradrenaline transporter in noradrenaline terminals (Miner et al., 2006). In 
turn, the basal low levels of noradrenaline could potentiate the stress induced release due to 
a lower inhibitory tone through autoreceptors. Added to this, it has been reported a reduced 
availability of noradrenaline transporter in the locus coerulerus of PTSD patients, which may 
result in exaggerated synaptic availability of noradrenaline in projection areas (Pietrzak et al., 
2013). To our knowledge, there are only two previous studies examining the content of 
noradrenaline or its metabolites in the amygdala of rats previously exposed to traumatic 
stress showing inconsistent results (Hendriksen et al., 2010; Tsuda et al., 1986). Tsuda et al. 
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reported that noradrenaline turnover (evaluated by measuring the levels of the noradrenaline 
metabolite MHPG-SO4) induced by psychological stress is enhanced in the amygdala of rats 
previously exposed to foot-shock (Tsuda et al., 1986). Hendriksen et al have shown no 
changes of noradrenaline levels in the amygdala, prefrontal cortex and hippocampus 
following IFS (Hendriksen et al., 2010). In contrast, in the present study we describe the 
differential dynamics of basal and stimulated noradrenaline outflow in the amygdala of IFS 
and control animals. These changes of noradrenaline release in the amygdala may mediate 
the behavioral effects of the exposure to IFS. 
 
The hypothesis of an exacerbated noradrenergic activity in the amygdala being responsible 
of hyperarousal symptoms of PTSD is further supported by the finding that microinjections of 
the β-adrenoreceptor antagonist propranolol in the amygdala counteract the reduced 
exploratory activity produced by IFS. Interestingly, since propranolol significantly reduced 
locomotion in control animals, the increase in activity observed in IFS rats seems to be a 
specific action of propranolol blocking the effects of an enhanced noradrenergic transmission 
in the amygdala. This result is in line with a previous study showing that systemic treatment 
with pharmacological agents that reduce noradrenergic transmission normalized startle 
response in mice exposed to IFS (Olson et al., 2011). Interestingly, there are a number of 
case reports suggesting that propranolol may ameliorate hyperarousal in PTSD patients who 
have had only partial response to other therapies (Strawn and Geracioti, 2008). In order to 
know whether an increase in noradrenergic transmission in the amygdala is enough to 
induce hyperarousal, we locally injected the specific β2-adrenoreceptor agonist clenbuterol 
before exposing control animals to an unknown environment (open field arena). 
Microinjections of clenbuterol in the amygdala of control animals did not change their 
exploratory activity. The dose of clenbuterol used here is in the range of those used to 
modulate memory when injected in the amygdala (Introini-Collison et al., 1995; LaLumiere 
and McGaugh, 2005). The results of clenbuterol injections suggest that the increased 
noradrenergic activity in the amygdala is not sufficient to induce hyperarousal. Alternatively, 
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the effects of a hypernoradrenergic state in the amygdala could be mediated by β1-
adrenoreceptors since propranolol is a nonselective beta blocker. Also, an increased activity 
of other neurotransmitter systems in the amygdala such as the serotoninergic projections 
from the raphe (Bailey et al., 2013; Hendriksen et al., 2014; Pitman et al., 2012) might be 
necessary for the expression of hyperarousal symptoms.  
 
Added to the increase in the release of noradrenaline in the amygdala, a change in the 
expression of adrenoreceptors could be involved in the effects of IFS on the activity in a 
novel environment. This would be in agreement with clinical studies demonstrating that 
PTSD patients show increased noradrenergic responsiveness that may contribute to 
symptomatology (Boehnlein and Kinzie, 2007; Southwick et al., 1993). Therefore, we 
evaluated the mRNA levels of β1- and β2-adrenergic receptors in the amygdala. Previous 
studies have shown that the alteration in the activity of the circuit prefrontal cortex-
hippocampus-amygdala is involved in the pathophysiology of PTSD (Bailey et al., 2013; 
Hendriksen et al., 2014; Pitman et al., 2012). Thus, we evaluated the expression of the β-
adrenergic receptors in these three areas of the brain (see table 2). IFS did not significantly 
modify mRNA levels of β-adrenergic receptors in the amygdala or the prefrontal cortex. 
However, β-adrenergic receptors were overexpressed in the hippocampus of IFS animals. 
First, these results suggest that the effects of noradrenaline in the amygdala inducing 
hyperarousal in IFS animals seem not to be mediated by an increase in the expression of β-
adrenergic receptors. Interestingly, the enhanced expression of these receptors in the 
hippocampus suggests that increased noradrenaline transmission in this area of the brain 
could be involved in the pathophysiology of PTSD (Acheson et al., 2012; O'Donnell et al., 
2004). As mentioned before, the microinjections of clenbuterol in the amygdala did not have 
any effect on the activity of control animals. Therefore, the above mentioned hypothesis 
would be in agreement with our results with clenbuterol.  
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Finally, the reduced locomotion and rearing activity in a novel environment (open-field arena) 
after exposure to IFS has been considered as an anxiogenic effect comparable to the 
hyperarousal observed in PTSD patients (Hendriksen et al., 2010; Hendriksen et al., 2012; 
van Dijken et al., 1992). However, it has been reported that ACTH levels are not changed 
after exposure to a novel environment in rats previously exposed to a session of three 
shocks, suggesting that the reduced locomotion in unknown environments is not linked to a 
marked increase in fear (Daviu et al., 2010). It is of interest the fact that increases of ACTH 
are produced when the rats are exposed to novel stressors when longer-lasting sessions of 
shocks were used (van Dijken et al., 1993). Daviu et al also showed that the reduced activity 
to novel environments is not observed when fear to the original shock context was prevented 
by shocking the animals immediately after exposure to the IFS-apparatus (Daviu et al., 
2010). Interestingly, Siegmund and Wotjak reported that the pharmacological reduction of the 
conditioned-fear response to the shock context did not modify the fear response to a neutral 
tone in a new context, suggesting that hyperarousal depends on sensitization induced by IFS 
(Siegmund and Wotjak, 2007). These findings suggest that the reduced activity induced by 
IFS seems to be a conditioned behavior that can be confounded with hyperarousal. As we 
report here, IFS does not produce a general hypoactivity since the reduction in locomotion 
and rearing is only observed during the first five minutes of the test. This latter finding 
highlights the strong translational value of the test in regard to the stress-sensitization as one 
of the core symptoms of PTSD, along with the exaggerated response to trauma cues (Chen 
et al., 2012; Hendriksen et al., 2012; Korem and Akirav, 2014; Siegmund and Wotjak, 2007).  
 
In conclusion, IFS exposure in rats enhanced stress-induced noradrenaline extracellular 
concentration in the amygdala and reduced locomotion in a novel environment as an index of 
PTSD-like hyperarousal. Moreover, the blockade of β-adrenergic receptors through local 
injections of propranolol in the amygdala counteracted the reduced exploratory activity 
produced by IFS. To our knowledge, these results show for the first time that an increased 
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noradrenergic activity in the amygdala contributes to the expression of hyperarousal behavior 
in an animal model of PTSD. 
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Figure Legends 
Figure 1. Diagram showing the design of the 3 set of experiments performed: a) Evaluation 
of behavioral effects of IFS and mRNA quantification; b) Microdialysis experiments; and c) 
Microinjection experiments. 
 
Figure 2. Effect of IFS on novelty-induced exploratory activity in an open field apparatus. 
The temporal profiles represent A) locomotion in cm and B) rearing in counts in IFS (n=9) 
and control (n=10) rats. Insets: Activity during the first 5 minutes. Data are presented as 
mean ± SEM. ***p<0.001 compared to control, according to planned comparisons analysis in 
a 2-way (group x time) ANOVA with repeated measures. 
 
Figure 3. Hystochemical analysis. A) Representative photomicrograph illustrating the 
placement of the membrane probe in the BLA for microdialysis. B) Approximate location of 
the microdialysis membrane in the amygdala of all animals included in the analysis. C) 
Representative micrograph illustrating the placement of the cannula in the BLA for 
microinjections experiments. D) Approximate location of the injection cannula in the 
amygdala of all animals included in the analysis. Abbreviations of amygdala areas: BA - 
basal nucleus; BLA - basolateral region; LA - lateral nucleus; M - medial nucleus. 
 
Figure 4. Effect of restraint stress (40 minutes) in IFS and control animals on extracellular 
concentration of noradrenaline in the amygdala of the rat. Data (mean ± SEM) represent the 
temporal profile as percentage of the baseline dialysate concentration of neurotransmitter. 
The number of animals is shown in parenthesis. *p< 0.05 compared to control animals, 
according to planned comparisons in a 2-way (group x time) ANOVA with repeated 
measures. 
 
Figure 5. Effects of bilateral microinjections of the β-adrenergic receptors antagonist 
propranolol (0.5 µg) into the amygdala on the exploratory activity in response to novelty in 
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IFS and control animals. Upper graph shows the effects of vehicle and propranolol (Prop) 
microinjections in control (n=8) and IFS (n=8-9) animals on locomotion. Bottom graph shows 
the effects of vehicle and propranolol (Prop) microinjections in control (n=8) and IFS (n=8-9) 
animals on rearing activity. Data (mean ± SEM) are expressed in centimeters for locomotion 
and counts for rearing. ##p< 0.01, ###p< 0.001 compared to vehicle; ***p< 0.01 compared to 
control, according to planned comparisons analysis in a 2-way ANOVA. 
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Tables 
 
Table 1 
Effects of microinjections of propranolol and clenbuterol in the amygdala on the exploratory activity 
induced by novelty in an open field. 
IFS animals LOCOMOTION REARING 
Vehicle (n=8)      363.23 ± 62.04 13.71 ± 2.68 
Propranolol 
0.1 µg (n=7)      635.91 ± 153.87     46.00 ± 7.09** 
0.5µg (n=9)      755.64 ± 84.66**     39.78 ± 6.13** 
1.5µg (n=6)      743.89 ± 77.18*        50.67 ± 9.21 *** 
   
Control animals LOCOMOTION REARING 
Vehicle (n=8) 1067.67± 35.66 60.94 ± 8.29 
Clenbuterol 30 ng (n=7)  989.52 ± 94.72 72.43 ± 5.69 
Data (mean ± SEM) are show in cm for locomotion and counts for rearing (vertical activity). *** p< 
0.001, ** p< 0.01, *p< 0.05 compared to vehicle according to planned comparisons in a 1-way 
ANOVA. 
 
 
 
 
 
Table 2  
mRNA content of β1 and  β2 adrenoreceptors in the amygdala, medial prefrontal cortex (mPFC) and 
dorsal hippocampus (dHC). 
 AMYGDALA mPFC dHC 
 CONTROL (n= 8-10) 
IFS 
(n= 8-9) 
CONTROL 
(n= 9-10) 
IFS 
(n= 8-9) 
CONTROL 
(n= 7-8) 
IFS 
(n= 7-8) 
ADRβ1 1.00 ± 0.08 0.82 ± 0.06 1.00 ± 0.14 0.85 ± 0.05 1.00 ± 0.14 1.53 ± 0.15* 
ADRβ2 1.00 ± 0.07 0.99 ± 0.07 1.00 ± 0.14 0.68 ± 0.07 1.00 ± 0.08 1.40 ± 0.15* 
Data (mean ± SEM) are show in absolute values (arbitrary units). *p<0.05 compared to control. 
Student t-test. 
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